Downloadable Slides

Share

Program Content

Activities

  • Immunotherapy for HNSCC
    Driving Progress in HNSCC: Integrating Immunotherapy and Novel Targeted Therapies Across the Disease Continuum
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 14, 2025

    Expires: November 13, 2026

Provided by

ProCE Banner

Supporters

Coherus BioSciences, Inc.

Merck Sharp & Dohme Corp.